Bone resorption in balance with bone formation is vital for the maintenance of the skeleton and is mediated by osteoclasts. Cathepsin K is the predominant protease in osteoclasts that degrades the bulk of the major bone forming organic component, type I collagen. Although the potent collagenase activity of cathepsin K is well known, its mechanism of action remains elusive. Here, we report a cathepsin K-specific complex with chondroitin sulfate, which is essential for the collagenolytic activity of the enzyme. The complex is an oligomer consisting of five cathepsin K and five chondroitin sulfate molecules. Only the complex exhibits potent triple helical collagen-degrading activity, whereas monomeric cathepsin K has no collagenase activity. The primary substrate specificity of cathepsin K is not altered by complex formation, suggesting that the protease-chondroitin sulfate complex primarily facilitates the destabilization and/or the specific binding of the triple helical collagen structure. Inhibition of complex formation leads to the loss of collagenolytic activity but does not impair the proteolytic activity of cathepsin K toward noncollagenous substrates. The physiological relevance of cathepsin K complexes is supported by the findings that (i) the content of chondroitin sulfate present in bone and accessible to cathepsin K activity is sufficient for complex formation and (ii) Y212C, a cathepsin K mutant that causes pycnodysostosis (a bone sclerosing disorder) and that has no collagenase activity but remains potent as a gelatinase, is unable to form complexes. These findings reveal a novel mechanism of bone collagen degradation and suggest that targeting cathepsin K complex formation would be an effective and specific treatment for diseases with excessive bone resorption such as osteoporosis.
Bone is undergoing a constant remodeling process that is balanced through the activities of bone-generating osteoblasts and bone-resorbing osteoclasts. Various bone diseases, such as osteoporosis, Paget's disease, certain forms of arthritis, and osseous metastases are characterized by excessive osteoclastmediated bone resorption. The resorptive step can be divided into two basic processes: (i) mineral solubilization and (ii) focalized matrix degradation. Whereas mineral solubilization depends on the production and secretion of acid by the osteoclast, matrix degradation is mainly due to the activity of the cysteine protease, cathepsin K (1, 2). Type I collagen constitutes 90 -95% of the organic bone mass (3) and represents the major biological substrate for cathepsin K (4) . Among all mammalian collagenases, cathepsin K is the only protease capable of cleaving interstitial collagens at multiple sites within their triple helical structures (5, 6) . Deficiency in cathepsin K activity leads to an accumulation of undigested collagen fibrils in lysosomes within osteoclasts (7) , as observed in patients with the autosomal recessive skeletal dysplasia pycnodysostosis (8) . Analysis of cathepsin K mutants revealed that the collagen degradation defect is not necessarily coupled with the loss of proteolytic activity of cathepsin K. One disease causing mutation, Y212C, that is remote from the active site of the protease, only mildly affected the overall proteolytic activity of cathepsin K but completely eliminated its collagenase activity (9) . This observation indicated that in addition to the catalytic activity of cathepsin K, other features are required for the hydrolysis of collagens by cathepsin K. We have recently demonstrated that bone-and cartilage-resident glycosaminoglycans specifically enhance the degradation of interstitial collagens of types I and II by cathepsin K, an effect not observed with cathepsin L or matrix metalloproteinase I (10) . This finding suggested that the collagenase activity of cathepsin K requires specific interactions between cathepsin K protein and glycosaminoglycans. The mechanism by which cathepsin K degrades collagen, however, remained elusive. In this report, we demonstrate that the collagenolytic activity of cathepsin K depends on the formation of a novel oligomeric complex of cathepsin K protein with chondroitin sulfate.
EXPERIMENTAL PROCEDURES
Enzymes and Complex Formation-Wild-type human cathepsin K and its mutant protein, Y212C, were expressed in Pichia pastoris and purified as described previously (9, 11) . Chondroitin 4-sulfate (C4-S) 1 was purchased from Sigma and fractionated on a Sephadex G-75 Superfine column. The molecular masses of the individual fractions were determined by dynamic light scattering (see below). Cathepsin K complexes were obtained by mixing purified cathepsin K and excess C4-S in acetate buffer, pH 5.0 containing 1 mM dithiothreitol (DTT) and 1 mM EDTA.
Size Exclusion Chromatography-40 g of purified recombinant human cathepsin K were preincubated with 0.1% C4-S (with 16-, 25-, and 29.8-kDa fractions, respectively, as determined by dynamic light scat-* This work was supported in part by National Institutes of Health Grants AR46182 and AR 48669. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
ʈ To whom correspondence should be addressed: Dept. tering, see below) in the elution buffer for 20 min and then applied to a Superdex200 column and eluted either in the presence or absence of 300 mM NaCl with 100 mM sodium acetate buffer, pH 5.5, containing 1 mM EDTA/DTT. Protein elution was monitored at 280 nm, and cathepsin K activity was assayed for the hydrolysis of the cathepsin K substrate Z-Leu-Arg-MCA as described previously (4) .
Substrate Assays using Z-Xaa-Arg-MCA Peptides-Steady state kinetics were performed with fluorogenic dipeptide substrates as described previously (4) . The enzymatic activity was followed by monitoring the release of the fluorogenic leaving group, MCA, at an excitation wavelength of 380 nm and an emission wavelength of 450 nm using the Molecular Devices SpectraMax Gemini spectro-microfluorimeter. The k cat and K m values were determined using nonlinear regression analysis. The cathepsin K activities were assayed at 25°C in the absence or presence of 0.1% C4-S at a fixed enzyme concentration (0.5 nM) and variable substrate concentrations (1-100 M) in 100 mM sodium acetate buffer, pH 5.5, containing 2.5 mM DTT and 2.5 mM EDTA. In addition, Z-Leu-Arg-MCA hydrolysis was assayed in the presence or absence of 300 mM NaCl. The active site concentration of cathepsin K and the mutant protein were determined by titration with E64 (12) .
Labeling of Cathepsin K and Electrophoretic Mobility Shift Assay-DCG-04, an epoxide inhibitor derivative of E64 containing a tyrosine residue for iodination and a biotin moiety (13) , was kindly provided by Dr. M. Bogyo, (Celera Corp., South San Francisco, CA). The compound was iodinated as described in Ref.
14. An aqueous solution of 15 M (0.1 Ci/ml) of [ 125 I]DCG-04 was incubated with recombinant human cathepsin K (or recombinant Y212C mutant; both at 2.5 M) in 100 mM acetate buffer, pH 5.0, containing 2.5 mM DTT and 2.5 mM EDTA for 4 h. Free inhibitor was removed by gel filtration using a PD-10 column (Amersham Biosciences). 50 ng of [ 125 I]DCG-04-labeled cathepsin K were preincubated in 100 mM sodium acetate buffer, pH 5.0, containing 1 mM EDTA/DTT in the presence or absence of 0.1% of C4-S, respectively, for 20 min and then mixed at 37°C with nonreducing protein loading buffer and preheated agarose gel. The sample was loaded into the well of a 0.5% agarose gel and separated at room temperature at 55 V, 250 mA for 30 min in a running buffer containing 125 mM sodium acetate, pH 5.0, 0.5 mM EDTA, 1 mM DTT, 40 mM NaCl, and 0.1% Chaps. The gel was dried and subsequently exposed to an x-ray film. To determine the effect of NaCl concentration on the formation of cathepsin K⅐C4-S complexes, labeled cathepsin K was incubated as described above in the presence of increasing NaCl concentrations (100, 200, and 300 mM). Equal salt concentrations were added to the agarose gel and the electrophoresis running buffer.
Determination of the Complex Ratio of Cathepsin K to C4-S-To determine the complex ratio between cathepsin K protein and C4-S, a constant amount of C4-S (292 pmol) was incubated with variable amounts of [ 125 I]DCG-04-labeled cathepsin K and then applied to 0.5% agarose gel electrophoresis. Electrophoretically separated bands of free cathepsin K represented the exact amount of cathepsin K in its free form in the equilibrium. The free form of labeled cathepsin K was detected by autoradiography and quantified by densitometry using a Personal Densitometer SI (Molecular Dynamics, Sunnyvale, CA). The free cathepsin K concentrations were determined using a calibration curve derived from known concentrations of cathepsin K. Plotting the quotient cathepsin K c /C4-S ([cathepsin K in complex] divided by [C4-S]; complex cathepsin K ϭ total cathepsin K-free cathepsin K) versus total cathepsin K concentration, the ratio between cathepsin K and C4-S in the complex could be determined. With increasing cathepsin K concentrations, the value for cathepsin K⅐C4-S increased until reaching saturation. The data could be fitted to the following equation, which was developed using the equilibrium equation and the assumption of a 1:1 complex,
where [CatK] t is the total cathepsin K concentration, [C] t is total C-4S concentration, and [CatK c ] is the cathepsin K concentration in the complex form. The saturation line of the curve represents the complex ratio of cathepsin K to C4-S.
Dynamic Light Scattering (DLS)-The molecular masses of monomeric cathepsin K, C4-S, and the CatK⅐C4-S complex were determined using a DynaPro-801 TC (ProteinSolutions, Inc., Charlottesville, VA) with helium/neon laser light scattering. The samples were dissolved in 100 mM sodium acetate buffer, pH 5.5, containing 80 mM NaCl. CatK⅐C4-S complexes were generated by mixing cathepsin K and C4-S (29.8-kDa fraction) at a ratio of 1:1. The data were analyzed using Dynamics 4.0 software (ProteinSolutions), and the molecular masses were calculated from experimental hydrodynamic radii using the Pullunan standard curve for C4-S and a globular protein standard for monomeric cathepsin K and its complex form.
Analytical Ultracentrifugation (Sedimentation Equilibrium)-The experiment was performed in the Optima XL-I Analytical Ultracentrifuge using a Beckman An50-Ti 8 hole rotor equipped with a six-sector charcoal-filled Epon centerpiece and quartz windows. The absorbance data were acquired at 280 nm as an average of 10 measurements at each radial position in 0.003-cm increments. A total of six data sets were collected corresponding to three different concentrations (10, 20 , and 50 M of cathepsin K and C4-S in 100 mM sodium acetate buffer, pH 5.5, containing 1 mM DTT, 1 mM EDTA, and 80 mM NaCl) and two speeds (6000 and 8000 rpm). Data editing and evaluation of the equilibrium were performed using the programs REEDIT and MATCH, respectively (provided by the National Analytical Ultracentrifugation facility of the University of Connecticut). The data were analyzed using the program NONLIN (15) allowing a global fit to s, where s ϭ M(1 Ϫ vD)w2/RT is the reduced apparent molecular mass. Calculation of the molecular mass was performed using molar masses (24.8 kDa for cathepsin K and 29.8 kDa for C4-S) and partial specific volumes (0.714 for protein and 0.58 for glycosaminoglycan) (16) .
Collagen and Gelatin Digests-0.4 mg/ml type I collagen (calf skin, Calbiochem) were incubated with human cathepsin K (800 nM) or its mutant protein (800 nM) in 100 mM sodium acetate buffer, pH 5.0, containing 2.5 mM DTT and EDTA. Collagen digestion was performed at 28 and 37°C in the absence and the presence of 0.15% (w/v) C4-S. Heat-denatured type I collagen (gelatin) was incubated with cathepsin K (0.5 nM) or its mutant (1 nM). The digestion reaction was stopped by the addition of 10 M E64 after 4 and 8 h. The samples were subjected to SDS-polyacrylamide electrophoresis using 4 -20% Tris/glycine gels that subsequently were stained with Coomassie Blue.
Deglycosylation of Collagen Samples-The glycosaminoglycans present in commercial type I collagen were removed by treatment with chondroitinase ABC. 100 l of 8 mg/ml collagen (U.S. Biochemical Corp.) in 100 mM sodium acetate buffer, pH 5.5, were incubated with 50 milliunits of chondroitinase ABC (Sigma) at 25°C for 4 h. The residual glycosaminoglycan content was determined as follows: 8 mg/ml collagen were heated at 70°C for 20 min and then incubated with 0.1 mg/ml pepsin at 25°C, pH 3.7, for 2 h. Glycosaminoglycan concentration was measured using the Blyscan glycosaminoglycan assay kit (Biocolor Ltd., Newtown Abbey, Northern Ireland).
Preparation of Human Bone Powder and Its Degradation by Cathepsin K-A human femoral head bone specimen obtained after hip joint replacement surgery was washed several time with ice-cold water and was milled under liquid nitrogen. The bone powder was defatted with acetone at 4°C for 2 h, washed with ice-cold water, and eventually demineralized in 10% formic acid for 3 days at 4°C with daily renewals of formic acid. Subsequently, the washed demineralized bone powder was freeze-dried. 4 mg of bone powder were degraded for 4 h with 800 nM cathepsin K at 25°C in 0.3 ml of 100 mM sodium acetate buffer, pH 5.5, containing 2.5 mM DTT and EDTA. The soluble glycosaminoglycan content was determined using the Blyscan glycosaminoglycan assay kit. For experiments to identify complex formation, glycosaminoglycan-containing supernatants were heat-inactivated at 70°C for 10 min after cathepsin K digestion. Heat-inactivated supernatants were then incubated with [ 125 I]DCG-04-labeled cathepsin K at room temperature. The samples were analyzed by the electrophoretic mobility shift assay as described above. As a control, supernatants of undigested bone powder were used.
RESULTS

Physico-kinetic Characterization of Cathepsin K-Chondroitin
Sulfate Complexes-Size exclusion chromatography of purified recombinant cathepsin K and C4-S mixtures revealed proteolytically active, high molecular mass complexes. The molecular masses varied between 180 and 310 kDa depending on the molecular mass fraction of C4-S used (16, 25 , and 29.8 kDa determined by dynamic light scattering) (Fig. 1A) . When cathepsin K⅐C4-S mixtures were eluted in the presence of 300 mM NaCl, cathepsin K activity corresponded to a peak of 25 kDa, which was identical to the elution peak obtained when cathepsin K was applied to the gel filtration column without C4-S. The complex form was also detected in an electrophoretic mobility shift assay using [
125 I]DCG-04-labeled cathepsin K in the presence of C4-S. Cathepsin K in the presence of C4-S migrated further to the anode than the enzyme without C4-S. In the presence of 0.3 M NaCl, the complex dissociated and cathepsin K migrated identically to the protease sample in the absence of C4-S (Fig. 1B) . For the dissociation of the complexes, NaCl concentrations of Ͼ0.2 M are required (Fig. 1B) .
The existence of high molecular mass cathepsin K⅐C4-S complexes was confirmed by DLS and analytical ultracentrifugation. Measurements by DLS yielded a molecular mass of 274 Ϯ 12 kDa, and the value obtained by ultracentrifugation was 285 kDa using the 29.8-kDa fraction of C4-S. Mobility shift assays allowed us to determine the ratio of [
125 I]DCG-04-labeled cathepsin K to C4-S in the complex. The plot of the amounts of cathepsin K c ⅐C4-S versus cathepsin K resulted in a saturation curve that reached a plateau at a 1:1 ratio of cathepsin K to C4-S (Fig. 2) . Based on the molecular mass of the complex determined by DLS and analytical ultracentrifugation and the ratio of 1:1 of cathepsin K to C4-S, we suggest the following stoichiometry for the complex: (CatK) 5 (C4-S) 5 . The calculated molecular mass of the complex is 275 kDa (based on the masses of its components: cathepsin K, 25.2 Ϯ 1.2 kDa, and C4-S, 29.8 Ϯ 3.2 kDa as determined by DLS) and is in close proximity to the experimental values obtained by DLS and ultracentrifugation. The hydrodynamic radius of the complex was determined by DLS to be 65 Ϯ 1.4 Å.
To determine whether chondroitin sulfate and sodium chloride affect the catalytic activity of cathepsin K, we determined the kinetic parameters for the cathepsin K-catalyzed hydrolysis of the synthetic fluorogenic substrate, Z-Leu-Arg-MCA, in the absence and presence of C4-S and sodium chloride, respectively (Table I) . C4-S increased the specificity constant, k cat /K m , 2-fold, which was equally reflected in slight decreases in the K m value and increases in the k cat value. NaCl had no or only a very weak effect on the appropriate K m and k cat values in the presence or the absence of C4-S. This suggests that the observed activating effect of C4-S on cathepsin K activity toward Z-Leu-Arg-MCA is not associated with the formation of high molecular cathepsin K complexes. A potential effect of complex formation on the substrate specificity of cathepsin K was excluded by the kinetic analysis of second order rate constants for the hydrolysis of dipeptide substrates (Z-Xaa-Arg-MCA, where Xaa ϭ Leu, Phe, Val, or Arg) in the presence or absence of C4-S. The formation of cathepsin K complexes had no effect on the substrate specificity of the S2 subsite pocket (Fig. 3) . The order of preference for P2 amino acid residues in the tested substrate series was identical in both assay conditions (Leu Ͼ Phe Ͼ Val Ͼ Arg), suggesting that the binding and cleavage preferences were identical in the free and the complex forms of cathepsin K.
Degradation of Triple Helical Collagen by Cathepsin K Complexes-Type I collagen was incubated with free cathepsin K or with cathepsin K⅐C4-S complexes at 28 and 37°C in the presence or absence of 300 mM NaCl. In the absence of NaCl, type I collagen was completely degraded by the protease⅐C4-S complex, whereas in the presence of NaCl cathepsin K alone or in a mixture with C4-S showed no or only a minimal degradation of the extracellular matrix protein even at 37°C (Fig. 4A) . Because the degradation of native collagen requires longer incubation times, the question was raised whether this activity is facilitated by an increased stability of the enzyme in the 125 I]DCG-04-labeled cathepsin K (0 -1425 pmol) were preincubated with 292 pmol of C4-S (30kD fraction) and separated by 0.5% agarose gel electrophoresis as described under "Experimental Procedures." After autoradiography, the signal of free cathepsin K was densitometrically determined, and the amount of cathepsin K in the complex was calculated (catK complex ϭ catK total Ϫ catK free ). Plotting the ratio catK complex /C4-S versus the catK total , a curve was obtained reaching a plateau at 1 for the catK complex to C4-S ratio. presence of C4-S. The residual activities listed in Table II indicate that both C4-S and NaCl stabilize cathepsin K activity. However, the stabilizing effects were nonadditive. Of note, there was no difference in the measured residual activities when the enzyme was incubated with C4-S alone or together with NaCl. Because the collagenolytic activity of cathepsin K⅐C4-S complexes was abrogated in the presence of NaCl, we conclude that the observed collagenolytic activity depends solely on the complex formation and not on the stabilization of the protease. In contrast, neither C4-S nor NaCl had any significant effect on the degradation of denatured type I collagen (gelatin) (Fig. 4B ). This indicates that complex formation is not required for the cathepsin K-catalyzed degradation of noncollagenous protein substrates. Contrary to this report, previous studies have shown a collagenolytic activity of cathepsin K in the apparent absence of chondroitin sulfate (4 -6) . This activity is probably caused by glycosaminoglycan contaminations in commercially available collagen preparations (approximately 0.2 g/ml in soluble type I calf skin collagen from Calbiochem after pepsin degradation). At this concentration, C4-S was sufficient to partially form cathepsin K⅐C4-S complexes and to exhibit a relatively minor but detectable collagenase activity as shown in Fig. 5 . A reduction of the glycosaminoglycan content in the collagen preparations by pretreatment with chondroitinase ABC resulted in a significant reduction of the collagenolytic activity of cathepsin K toward type I collagen (Fig. 5B ), whereas chondroitinase ABC had no effect on the activity of cathepsin K toward synthetic peptide substrates (data not shown). Thus, we conclude that the presence of traces of glycosaminoglycans in collagen preparations concealed the fact that monomeric cathepsin K does not have collagenolytic activity. With increasing C4-S concentrations, the collagenolytic activity dramatically increased and reached a maximum of activity at ϳ10 g/ml C4-S (ϳ500 nM), which was close to the protease concentration used in the assay. This again is suggestive for a cathepsin K to C4-S ratio of 1:1.
Glycosaminoglycan Content in Human Bone and Complex Formation-The main sources of chondroitin sulfates in human bone are the proteoglycans, decorin and biglycan. Following incubation of human bone powder with cathepsin K, glycosaminoglycans were found in the supernatant at a concentration of 0.1 mg/ml (0.75% of dry weight of bone powder), which probably only represents the amount of glycosaminoglycans released from the surface of the bone powder particles. Because no soluble glycosaminoglycans were detected prior to the treatment with cathepsin K, we suggest that the protease degrades proteoglycans and releases the glycosaminoglycans. When [
125 I]DCG-04-labeled cathepsin K was incubated with supernatants of cathepsin K-predigested bone, we observed a shift in the mobility in agarose gel electrophoresis typical for cathepsin K⅐C4-S complexes. Preincubation of labeled cathepsin K with supernatants of undigested bone did not show the shift, and the enzyme migrated identically to the free enzyme (Fig. 6) . These data clearly indicate that surface digestion of bone particles by cathepsin K releases sufficient amounts of glycosaminoglycans required for the generation of cathepsin K complexes. Moreover, they explain the collagenolytic activity of cathepsin K using bone powder as substrate as described previously by Garnero et al. (5) .
Lack of Complex Formation in Pycnodysostosis-causing Cathepsin K Mutant Protein-The data presented are derived from in vitro experiments and do not indicate whether complex formation is an in vitro artifact or a physiological feature of the collagenolytic activity of cathepsin K in vivo. To address this question, cathepsin K mutations that cause pycnodysostosis were reviewed. Nine mutations were either nonsense defects that obliterated the protein or missense mutations that resulted in unstable proteins (17) . A single mutation, Y212C, produced a cathepsin K polypeptide that lacked collagenase activity but retained its gelatinase activity (9) . When tested, no complex formation between Y212C and C4-S was observed (Fig. 7A) . Similar to cathepsin K in the absence of glycosaminoglycans, the Y212C protein did not have collagenase activity in the presence nor in the absence of C4-S, even at 37°C (Fig.  7B) . Thus, the lack of complex formation for the Y212C variant provides an explanation about the inability of this mutant to hydrolyze native collagen. In contrast, the gelatinase activities of wild-type and mutant Y212C cathepsin K in the presence of C4-S were comparable (Fig. 7C) , supporting the hypothesis that complex formation is required for the in vivo collagenase activity of cathepsin K but not for its action toward noncollagenous substrates.
DISCUSSION
Type I collagen constitutes the major organic component in bone and is subjected to a constant turnover during the bone remodeling process. Only a few proteases are capable of degrading native triple helical collagens. Besides cathepsin K, several members of the matrix metalloproteinase (MMP) family are classified as mammalian collagenases. MMPs cleave interstitial collagens at a distinct Gly-(Ile/Leu) bond to generate 3 ⁄4 and 1 ⁄4 fragments (18), whereas cathepsin K, similar to bacterial collagenase (19) , degrades native collagen into small peptides. In this report, we demonstrated that cathepsin K collagenase activity requires the formation of a unique pentameric protein-glycosaminoglycan complex consisting of cathepsin K and chondroitin sulfate molecules at a 1:1 molar ratio. Because both activity and specificity of the complex toward synthetic peptide substrates do not reveal major changes when compared with those of the enzyme in the absence of C4-S, molecular interactions responsible for the formation of the complex appear to alter neither the integrity of the catalytic site nor the geometry of the primary substrate-binding pocket, S2, in cathepsin K.
Dissociation of the cathepsin K⅐C4-S complex in the presence of high salt concentration (300 mM) specifically abrogates the collagenase activity while still allowing the efficient hydrolysis of synthetic peptide substrates and gelatin. It should be noted that the inhibition of collagen degradation in the presence of 300 mM NaCl can not be attributed to a stabilization of the collagen structure by salt because, on the contrary, NaCl slightly destabilizes type I collagen (20) . Similarly, the absence of chondroitin sulfate also prevents the collagenase activity of cathepsin K. This suggests that monomeric cathepsin K and cathepsin K in the absence of C4-S has no or only a minimal collagenase activity, which is highly reminiscent of the lack of collagenase activities in the catalytic domains of MMP collagenases (21, 22) . Collagenases of the MMP family require, in addition to their catalytic sites, at least three structural elements for their collagenolytic activity: (i) a hemopexin-like C-terminal domain, (ii) a linker or hinge region between the catalytic and hemopexin domain, and (iii) a specific peptide loop in the catalytic domain (23) (24) (25) (26) . None of these structural features required for the helicase activity of MMPs (27) are present in cathepsin K or related cysteine proteases, suggesting that cathepsin K utilizes a very different mechanism to cleave triple helical collagen.
The diameter of the binding cleft of monomeric cathepsin K is ϳ5 Å wide (28) and thus well too narrow to accommodate a collagen triple helix with a diameter of 15 Å. Because a dramatic widening of the active site cleft in the protease complex would probably lead to significant changes in the catalytic and specificity parameters of the enzyme (both were not observed), it is tempting to hypothesize that the cathepsin K-chondroitin sulfate complex might act as a functional equivalent of the hemopexin and hinge domains in MMPs and will facilitate the correct orientation of the triple helical collagen domain to the active site of the protease and/or the local unfolding/destabilization of the triple helix to permit cleavage. Exactly how the complex facilitates the destabilization/cleavage of the triple helix still remains elusive. Preliminary studies derived from electron microscopy experiments suggests that the cathepsin K-chondroitin complex may form flexible ring-like structures with a central pore sufficiently wide to accommodate the collagen helix of 15 Å in diameter. 2 However, this structure raises the question of how a doughnut-like structure can accommodate large collagen fibrils, the physiological form of the substrate present in bone. This would require an opening mechanism of the ring structure. We hope that ongoing crystallography experiments will answer these questions in the near future.
An alternative explanation of the stimulating effect of chondroitin sulfate on the collagenolytic activity of cathepsin K would be a destabilization of the triple helical collagen structure by the glycosaminoglycan. This, however, is unlikely because (i) also in the presence of chondroitin sulfate, the pycnodysostosis-causing mutant, Y212C, and other cysteine proteases such as cathepsins L and S did not display collagenase activities and (ii) the melting temperature of type I collagen was not affected by chondroitin sulfate. 3 The lack of effects on the substrate activity and specificity on cathepsin K in the presence of chondroitin sulfate is in agreement with previous observations made regarding papain and cathepsin B (29, 30) . Interestingly and contrary to chondroitin sulfates, heparan sulfate significantly altered the ␣-helix content of papain and cathepsin B (29, 30) . Almeida et al. (29, 30) observed a stabilization of papain and cathepsin B at alkaline pH in the presence of heparan sulfate and hypothesized that the polysaccharide stabilizes the ␣-helix content of the proteases and thus probably prevents alkaline denaturation. In the case of cathepsin K, there is no indication that C4-S stabi-2 D. Brömme, unpublished data. 3 G. Fields and D. Brömme, unpublished data.
FIG. 4.
Triple helical type I collagen degradation by cathepsin K⅐C4-S complexes is completely inhibited in the presence of 300 mM NaCl (A), whereas NaCl has no effect on cathepsin K-mediated hydrolysis of gelatin (B). It should be noted that also at body temperature of 37°C, collagen degradation requires cathepsin K complex formation. lizes the enzyme at pH values above 7. We have previously shown that the pK b values of pH activity profiles in the absence or presence of C4-S do not show statistically relevant differences and that the protease does not exhibit any collagenase activity above pH 7.0 whether or not C4-S is present (10) . All of these observations suggest that the interactions of cathepsin K with C4-S have no effect on the structural integrity of the protease within the complex. Because the protease⅐C4-S complex dissociates at high salt concentrations, it can be concluded that the binding interactions are of an electrostatic nature. The C4-S-binding sites in cathepsin K still remain unknown. However, electrostatic surface potential maps reveal clusters of positively charged arginine and lysine residues on the "back side" (opposite to the binding cleft of the protease; data not shown). These clusters are unique for cathepsin K when compared with other cysteine proteases such as cathepsins S, L, and B and are presently subjected to site-directed mutagenesis analyses. That these basic residues are candidates for specific cathepsin K⅐C4-S binding interactions is also supported by the finding that cathepsins S, L, and B, which are lacking comparable positively charged surface patches, do not form high molecular complexes with C4-S 2 and that the interactions with the glycosaminoglycan do not alter the activity and specificity toward small molecule substrates. In contrast, electrostatic interactions between heparan sulfate and cathepsin B or papain have been localized or proposed close to the active sites of both proteases. Almeida et al. (29) demonstrated that heparin sulfate binds to the occluding loop of cathepsin B that is responsible for the dipeptidyl peptidase activity of the enzyme. For papain they proposed interactions in the vicinity of the catalytic site (30) . Consequently, the binding of heparin sulfate affected the catalytic parameters toward synthetic substrates in both proteases.
The dissociation of collagenolytically active cathepsin K complexes at high salt concentration raises the question of whether salt concentrations present in the resorption lacuna or intracellularly in osteoclasts could be high enough to prevent collagen degradation via this mechanism. Based on published intracellular Ca 2ϩ concentrations in osteoclasts and extracellular concentrations after stimulation of bone resorption in the low millimolar range (31, 32) , it is unlikely that in vivo salt concentration will be inhibitory. 20 mM calcium did not affect the complex formation. 2 Our in vitro experiments indicate that salt concentrations of Ͼ200 mM are required for complex dissociation.
If cathepsin K⅐C4-S complex formation is of physiological relevance in bone remodeling, chondroitin sulfates must be present at sufficient concentrations in bone. C4-S constitutes some 90% of the total glycosaminoglycan content in bone and is mostly present in proteoglycans such as decorin and biglycan (33) . Both proteoglycans bind to collagens (34) and are most likely phagocytosed and degraded by osteoclasts during bone resorption. Thus, it is highly likely that osteoclast-expressed cathepsin K is in contact with abundant amounts of C4-S in the resorption lacuna underneath osteoclasts as well as within the lysosomal compartment. Our in vitro bone degradation experiments support this notion. Cathepsin K activity alone was sufficient to release glycosaminoglycans from bone particles at a concentration of 0.1 mg/ml, allowing the formation of collagenolytically active protease complexes (Fig. 6) .
Although no experimental tools are presently available to demonstrate the in situ expression of cathepsin K⅐C4-S complexes in osteoclasts, the analysis of pycnodysostosis-causing cathepsin K mutations strongly supports the existence of cathepsin K⅐C4-S complexes. We have previously characterized a missense mutation in the cathepsin K gene (Y212C) that encoded a cathepsin K protein exhibiting a significant proteolytic activity but completely lacking the ability of the wild-type enzyme to degrade type I collagen (9) . The child with pycnodysostosis who had inherited the Y212C mutation also had inherited the nonsense allele, R241X. The phenotype associated with compound heterozygosity for Y212C and R241X was typical for pycnodysostosis. Based on these findings and the fact that carriers of all single pycnodysostosis alleles are asymptomatic, we concluded that pycnodysostosis is specifically caused by the deficiency of the collagenolytic activity of cathepsin K and not by the absence of cathepsin K protein or all of its protease activity. Because Tyr 212 resides on the surface and distant from the active site of cathepsin K, it was unclear how Y212C obliterated the collagenase activity of the protease. Our demonstration that this mutant is unable to form a complex is clearly suggestive that cathepsin K complex formation is required for in vivo osteoclast-mediated bone resorption. Furthermore, the absence of complex formation by the Y212C mutant advocates that this site is directly or indirectly involved FIG. 5 . A, cathepsin K complex formation is observed at low C4-S concentrations (0.2 g/ml) that are present in collagen substrate samples. B, hydrolysis of type I collagen by cathepsin K is dependent on the presence of C4-S and is specifically enhanced by increasing concentrations of C4-S. With the exception of variable C4-S concentrations, the conditions for the digest assay are identical to those described for Fig. 5 . *, treatment of the collagen sample with chondroitinase ABC reduced the amount of C4-S to less than 0.1 g/ml. in the binding of C4-S or in protein-protein interactions between cathepsin K monomers. Using nonreducing SDS-polyacrylamide electrophoresis, we could exclude the possibility that complex formation is inhibited by the dimerization of two cathepsin K molecules via the mutant cysteine residue. No dimers were observed (data not shown).
In summary, we have demonstrated that monomeric cathepsin K has no triple helical collagen cleaving activity and that the physiologically relevant collagenase activity in bone resorption depends on the generation of a pentameric cathepsin K complex stabilized by chondroitin sulfate. The fact that the cathepsin K mutant Y212C causes the bone resorption disorder, pycnodysostosis, is due to the loss of the ability of cathepsin K to form complexes with C4-S. The discovery of cathepsin K⅐C4-S complexes as the collagenolytically active form of cathepsin K will allow the understanding of the mechanism of degradation of the most abundant protein, type I collagen, in vertebrates. Further experiments are directed to the elucidation of the structure of the complex, the identification of binding sites for C4-S, the identification of complex formation inhibitors, and the regulation of the collagenase activity by various physiologically relevant glycosaminoglycans. A precise understanding of the molecular interactions responsible for complex formation and regulation of its activity may lead to the design of compounds that would inhibit osteoporosis by selectively interfering with the collagenase activity of cathepsin K but without affecting the essential activity of the monomeric enzyme. FIG. 7 . The pycnodysostosis-causing cathepsin K mutant, Y212C, does not form complexes in the presence of C4-S as observed for wild-type cathepsin K (A). The lack of complex formation correlates with the inability of Y212C to hydrolyze type I collagen (B) but does not interfere with its gelatinase activity (C). Temp., temperature.
